Replies to post #480 on Resverlogix Corp. (RVXCF)

[growacet]

We'll see if your opinion bears out....

The question of whether BETonMACE is sufficiently powered or not has been out there for a long time, at $1.30 and even when the PPS was over $2 CDN so personally I don't see it as a driving factor right now.

Financing is another matter altogether imo....without the Thrid Eye loan there isn't enough money to take the trial to the finish line, even if 2,400 patients and 250 MAC events is enough.